Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 2, 2001, Pages 575-582

  Chu, Xiao Yan ^a   Sánchez Castaño, Gloria P ^b   Higaki, Kazutaka ^a   Oh, Doo Man ^a   Hsu, Cheng Pang ^a   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; COMPLEMENTARY DNA; PROTON COUPLED OLIGOPEPTIDE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ILEUM MUCOSA; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; JEJUNUM MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

NON-PROGRAMMATIC;

ALGORITHMS; ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; CARRIER PROTEINS; CELL MEMBRANE PERMEABILITY; CEPHALEXIN; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; HUMANS; INTESTINAL ABSORPTION; KINETICS; MALE; PERFUSION; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; SYMPORTERS;

EID: 0034763141     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Analysis of models for determining intestinal wall permeability
2. Estimating human oral fraction dose absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds
3. Structural requirements for the intestinal mucosal-cell peptide transport: The need for N-terminal α-amino group
4. +/peptide symporter (PEPT1), and the uptake into Caco-2 cell monolayers and the transepithelial flux
5. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells
6. Carrier-mediated uptake of cephalexin in human intestinal cells
7. Uptake of the cephalosporin, cephalexin, by the dipeptide transport carrier in the human intestinal cell line, Caco-2
8. Association of intestinal peptide transport with a protein related to the cadherin superfamily
9. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model
10. Expression cloning of a mammalian proton-coupled oligopeptide transporter
11. +/di-tripeptide transporter (PepT1) expression in the rabbit intestine
12. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPs-1 and Capon-2
13. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter
14. Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction
15. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport system in apical and basolateral membranes
16. Determination of intrinsic membrane transport parameters from perfused intestine experiments: A boundary layer approach to estimating the aqueous and unbiased membrane permeabilities
17. High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine
18. Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and β-lactam antibiotics
19. Intestinal absorption of β-lactam antibiotics and oligopeptides. Functional and stereospecific reconstitution of the oligopeptide transport system from rabbit small intestine
20. The intestinal oligopeptide transporter: Molecular characterization and substrate specificity
21. +/oligopeptide transport system from rabbit small intestine
22. +/peptide cotransporter cloning, functional expression and chromosomal localization
23. +/peptide cotransporter family, from human kidney
24. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression
25. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test
26. Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter
27. +/peptide cotransporter in rat digestive tract
28. Characterization of the oral absorption of β-lactam antibiotics. I. Cephalosporins: Determination of intrinsic membrane absorption parameters in the rat intestine in situ
29. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells
30. Saturable absorption of amino-cephalosporins by the rat intestine
31. Comparison of enhanced chemiluminescence and colorimetric techniques for the immuno-detection of alpha 1-antitrypsin
32. The intestinal peptide carrier: A potential transport system for small peptide derived drugs
33. Substrate upregulation of the human small intestinal peptide transporter, hPEPT1
34. Intestinal absorption aspect of non-lipophilic low molecular weight drugs: A case of cephalexin and cefazolin
35. Intestinal peptide transport systems and oral drug availability
36. Oral absorption of angiotensin-converting enzyme inhibitors and peptide prodrugs